HomeCompareTCDA vs BTI

TCDA vs BTI: Dividend Comparison 2026

TCDA yields 1851.85% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCDA wins by $4863045258.28M in total portfolio value
10 years
TCDA
TCDA
● Live price
1851.85%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4863045258.31M
Annual income
$4,396,067,798,536,862.00
Full TCDA calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — TCDA vs BTI

📍 TCDA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCDABTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCDA + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCDA pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCDA
Annual income on $10K today (after 15% tax)
$157,407.41/yr
After 10yr DRIP, annual income (after tax)
$3,736,657,628,756,332.50/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, TCDA beats the other by $3,736,657,628,753,964.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCDA + BTI for your $10,000?

TCDA: 50%BTI: 50%
100% BTI50/50100% TCDA
Portfolio after 10yr
$2431522629.18M
Annual income
$2,198,033,899,269,824.20/yr
Blended yield
90.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

TCDA
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Price Target
$16.00
+14714.8% upside vs current
Range: $16.00 — $16.00
Altman Z
-16.7
Piotroski
1/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCDA buys
0
BTI buys
0
No recent congressional trades found for TCDA or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCDABTI
Forward yield1851.85%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$4863045258.31M$37.7K
Annual income after 10y$4,396,067,798,536,862.00$2,786.64
Total dividends collected$4829695825.56M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$16.00$40.00

Year-by-year: TCDA vs BTI ($10,000, DRIP)

YearTCDA PortfolioTCDA Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$195,885$185,185.19$11,299$598.92+$184.6KTCDA
2$3,599,787$3,390,190.12$12,794$703.91+$3.59MTCDA
3$62,077,580$58,225,807.67$14,518$829.07+$62.06MTCDA
4$1,004,826,655$938,403,644.40$16,513$978.64+$1004.81MTCDA
5$15,271,043,115$14,195,878,594.10$18,827$1,157.84+$15271.02MTCDA
6$217,970,436,268$201,630,420,135.20$21,518$1,373.12+$217970.41MTCDA
7$2,922,911,796,978$2,689,683,430,171.31$24,657$1,632.46+$2922911.77MTCDA
8$36,835,711,310,169$33,708,195,687,401.73$28,329$1,945.74+$36835711.28MTCDA
9$436,427,532,502,759$397,013,321,400,878.75$32,637$2,325.33+$436427532.47MTCDA
10$4,863,045,258,314,815$4,396,067,798,536,862.00$37,708$2,786.64+$4863045258.28MTCDA

TCDA vs BTI: Complete Analysis 2026

TCDAStock

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Full TCDA Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this TCDA vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCDA vs SCHDTCDA vs JEPITCDA vs OTCDA vs KOTCDA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.